Synthesis, antioxidant and carbonic anhydrase I and II inhibitory activities of novel sulphonamide-substituted coumarylthiazole derivatives

dc.authorid0000-0001-7092-8857en_US
dc.contributor.authorKurt, Belma Zengin
dc.contributor.authorSönmez, Fatih
dc.contributor.authorBilen, Çiğdem
dc.contributor.authorErgün, Adem
dc.contributor.authorGençer, Nahit
dc.contributor.authorArslan, Oktay
dc.contributor.authorKüçükislamoğlu, Mustafa
dc.date.accessioned2019-10-17T11:33:43Z
dc.date.available2019-10-17T11:33:43Z
dc.date.issued2016en_US
dc.departmentFakülteler, Fen-Edebiyat Fakültesi, Kimya Bölümüen_US
dc.descriptionBilen, Çiğdem (Balikesir Author)en_US
dc.description.abstractNew secondary benzenesulphonamide-substituted coumarylthiazole derivatives were synthesized and their inhibitory effects on purified carbonic anhydrase I and II were evaluated using CO2 as a substrate. The result showed that all the synthesized compounds exhibited inhibitory activity on both hCA I and hCA II with N-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl) naphthalene-2-sulphonamide (5f, IC50 value of 5.63 and 8.48 mu M, against hCA I and hCA II, respectively) as the strongest inhibitor revealed from this study. Structure-activity relationship revealed that the inhibitory activity of the synthesized compounds is related to the type of the halogen and bulky substituent on the phenyl ring. In addition, the cupric reducing antioxidant capacities (CUPRAC) and ABTS cation radical scavenging abilities of the synthesized compounds were assayed. 4-methoxy-N-(4-(2-oxo-2H-chromen-3-yl) thiazol-2-yl) benzenesulphonamide (5e) exhibited the strongest ABTS and CUPRAC activity with IC50 value of 48.83 mu M and A(0.50) value of 23.29 mu M ,en_US
dc.description.sponsorshipSakarya University - 2014-28-00-001en_US
dc.identifier.doi10.3109/14756366.2015.1077823
dc.identifier.endpage998en_US
dc.identifier.issn1475-6366
dc.identifier.issn1475-6374
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-84941346908
dc.identifier.scopusqualityQ1
dc.identifier.startpage991en_US
dc.identifier.urihttps://doi.org/ 10.3109/14756366.2015.1077823
dc.identifier.urihttps://hdl.handle.net/20.500.12462/8574
dc.identifier.volume31en_US
dc.identifier.wosWOS:000385270300017
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectABTSen_US
dc.subjectAntioxidanten_US
dc.subjectCarbonic Anhydraseen_US
dc.subjectCoumarinen_US
dc.subjectCUPRACen_US
dc.subjectSulphonamideen_US
dc.titleSynthesis, antioxidant and carbonic anhydrase I and II inhibitory activities of novel sulphonamide-substituted coumarylthiazole derivativesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
cigdem-bilen.pdf
Boyut:
1.22 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: